Total raised
$24.5M
Last: Series A 2024-06
Stage
Series A
Founded
2011
Headcount
34
HQ
Modi'in-Maccabim-Re'ut
Sector
Health Tech & Life Sciences
About
OCON Therapeutics innovates, develops, manufactures, and commercializes women's health products based on its proprietary and patented intrauterine ball (IUB) platform. Made from the super-elastic alloy nitinol, the IUB is an ideal carrier of multiple drugs to the uterus for treating a variety of conditions.
In addition to its flagship product, the IUB Ballerine, OCON Therapeutics is developing a pipeline of products utilizing the IUB frame for indications including abnormal uterine bleeding, heavy menstrual bleeding, myomas and fibroids, and infertility.
Funding history · 3 rounds · $24.5M total
2024-06
Series A
$10.0M
2020-12
Series A
$4.5M
2020-06
Undisclosed
$2.0M
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is OCON Therapeutics' primary focus?
- OCON Therapeutics focuses on innovating, developing, manufacturing, and commercializing women's health products based on its proprietary and patented intrauterine ball (IUB) platform.
- What is the status of OCON Therapeutics as of April 2026?
- As of April 2026, OCON Therapeutics is inactive and has ceased to operate.
- When was OCON Therapeutics founded?
- OCON Therapeutics was founded in March 2011.
- What was the latest funding round for OCON Therapeutics?
- OCON Therapeutics completed a Series A funding round in June 2024, raising $10 million. Rhia Ventures was a lead investor in this round.
- Which company did OCON Healthcare sign an exclusive agreement with for product marketing in China and Southeast Asia?
- In June 2022, OCON Healthcare signed an exclusive agreement with BioGenuine to market its products in China and Southeast Asian countries.
- What recognition did OCON Healthcare receive from the World Economic Forum?
- In May 2022, OCON Healthcare was awarded as a Technology Pioneer by the World Economic Forum.
- What award did OCON Healthcare receive from Frost & Sullivan?
- In April 2021, OCON Healthcare received the 2021 Global Enabling Technology Leadership Award from Frost & Sullivan.
- Who was appointed Chairwoman of OCON Healthcare in December 2020?
- In December 2020, Dr. Anula Jayasuriya was appointed Chairwoman of OCON Healthcare following a funding round.
- What was the reported efficacy and safety data for OCON Healthcare's Smart IUB Ballerine in January 2021?
- In January 2021, OCON Healthcare announced positive long-term efficacy and safety data on over 100,000 users of its Smart IUB Ballerine hormone-free contraceptive.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsCommerce & RetailDistribution ChannelsDistributorConsumersDemographics & FamilyWomen
Business model
B2BB2C
Highlights
1 PatentsVerified
Tags
femtechpreventionmedical-productsmedical-devicespregnancygynecologywomen-healthnon-invasivewomenpatientstreatments